Verus Pharmaceuticals Overview
Verus Pharmaceuticals General Information
Description
Provider of solutions for the treatment of asthma, allergies, and related diseases and conditions. The company also offers Twinject, an epinephrine auto-injector for anaphylaxis. It is differentiated by its pediatric orientation and its strong financial position and experienced management team, which allows the company to capitalize on an extensive network to build its product portfolio and pursue complementary transactions.
Want to dig into this profile?
We’ll help you find what you need
Learn more
Verus Pharmaceuticals Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 2. Merger/Acquisition |
24-Sep-2007 |
$310M |
0000 |
00000 |
Completed |
Product Development |
| 1. Early Stage VC (Series A) |
10-Jun-2005 |
0000 |
0000 |
00000 |
Completed |
Product Development |
Verus Pharmaceuticals Executive Team (2)
| Name |
Title |
Board Seat |
Contact Info |
| Robert Keith |
President & Chief Executive Officer |
|
|
1 Former Executive
Verus Pharmaceuticals Exits (1)
| Company Name |
Exit Date |
Exit Type |
Exit Size |
Status |
Buyers |
| 000000000-00000 00 |
06-Jul-2005 |
000000000 00000 00 |
|
Completed |
|